Physician profile
Jay R Maust
NPI 1831180553
$526.21
in general payments reported to CMS, 2019-2025
13 companies · $48.90 in 2025
The $48.90 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $22.21 · 2021: $15.64 · 2022: $31.77 · 2023: $131 · 2024: $116 · 2025: $48.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $261.24 | 2022-2025 | Azstarys |
| Shire North American Group INC | $47.18 | 2019 | |
| Tris Pharma INC | $44.46 | 2019 | |
| Neos Therapeutics, LP | $32.59 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.21 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $18.00 | 2024 | Flumist Quadrivalent |
| Seqirus USA INC | $16.98 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.00 | 2024 | |
| Glaxosmithkline, LLC. | $15.64 | 2021 | |
| Ironshore Pharmaceuticals INC. | $15.20 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.89 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $11.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Maust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.